Karen J. Wilson, Director at Serina Therapeutics, Inc. (SER), bought 10,100 shares at $1.75 ($18K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market purchase of $18k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 5,100 | $9K | 50.1% |
| 2 | $1.77 | 5,000 | $9K | 49.9% |
| Total | $1.76 avg | 10,100 | $18K | 100% |
| Filing → |
| JAZZ | SELL | 2018-04-12 | $604K | — | Filing → |
| JAZZ | SELL | 2017-04-27 | $204K | — | Filing → |
| JAZZ | SELL | 2017-04-11 | $2.8M | — | Filing → |